ARTICLE | Company News
Oculus, Quinnova Pharmaceuticals Inc. sales and marketing update
February 21, 2011 8:00 AM UTC
Oculus granted Quinnova U.S. and Canadian rights to Epicyn Hydrogel for $500,000. The shelf-stable hypochlorous acid formulation that uses Oculus' Microcyn technology received FDA clearance earlier ...